Literature DB >> 17307438

Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.

Jocelyn N Clark-Greuel1, Jeanne M Connolly, Elizabeth Sorichillo, Navneet R Narula, H Scott Rapoport, Emile R Mohler, Joseph H Gorman, Robert C Gorman, Robert J Levy.   

Abstract

BACKGROUND: Aortic valve stenosis is the most frequent indication for valve replacement surgery, and is commonly associated with pathologic calcification. Previous investigations by our group have shown a strong association of transforming growth factor-beta1 (TGF-beta1)-related mechanisms with calcific aortic stenosis in both cell culture and clinical pathology studies.
METHODS: In the present investigations we sought to investigate the sequence of events involved in TGF-beta1-initiated aortic valve interstitial cell calcification in cell culture, and to study related gene expression pattern differences comparing calcific aortic stenosis surgical specimens with normal aortic valve leaflets.
RESULTS: Sheep aortic valve interstitial cells (SAVIC) in culture progressively calcified over 14 days after the addition of TGF-beta1 to a significantly greater extent than non-TGF-beta1 controls. The TGF-beta1-induced SAVIC calcification was associated with maximal levels of alkaline phosphatase by 72 hours. Annexin V positive apoptosis was increased in TGF-beta1-treated SAVIC cultures at 14 days compared with controls. Matrix metalloproteinase 9 per gel zymography was detectable only in SAVIC cultures treated with TGF-beta1 from seven days on. Matrix metalloproteinase 2 was present in all SAVIC cultures per gel zymograms, either with or without TGF-beta1, but the active form of matrix metalloproteinase 2 significantly increased over 14 days in response to TGF-beta1. Quantitative gene expression studies (re: RNA levels) of human aortic valve cusps obtained at cardiac surgery demonstrated a number of related trends, including upregulation of the expression of TGF-beta1, alkaline phosphatase, and matrix metalloproteinase 9 in calcified human aortic valves.
CONCLUSIONS: Transforming growth factor-beta1 causes SAVIC to calcify due to an early maximal increase in alkaline phosphatase activity with associated apoptotic events and increased matrix metalloproteinase 9. These TGF-beta1-related mechanistic events may be of clinical relevance based upon the gene expression pattern changes observed in calcific aortic stenosis valve cusps.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307438     DOI: 10.1016/j.athoracsur.2006.10.026

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  68 in total

Review 1.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

2.  Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.

Authors:  Jae-Joon Jung; Mahmoud Razavian; Azariyas A Challa; Lei Nie; Reza Golestani; Jiasheng Zhang; Yunpeng Ye; Kerry S Russell; Simon P Robinson; Donald D Heistad; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2015-04-23       Impact factor: 10.057

3.  Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner.

Authors:  Kartik Balachandran; Philippe Sucosky; Hanjoong Jo; Ajit P Yoganathan
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 4.  Calcific aortic valve stenosis: methods, models, and mechanisms.

Authors:  Jordan D Miller; Robert M Weiss; Donald D Heistad
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

5.  Bicuspid aortic valves experience increased strain as compared to tricuspid aortic valves.

Authors:  Kai Szeto; Peter Pastuszko; Juan C del Álamo; Juan Lasheras; Vishal Nigam
Journal:  World J Pediatr Congenit Heart Surg       Date:  2013-10

Review 6.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

Review 7.  Mechanisms of calcification in aortic valve disease: role of mechanokinetics and mechanodynamics.

Authors:  W David Merryman; Frederick J Schoen
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

8.  Regulation of valvular interstitial cell calcification by adhesive peptide sequences.

Authors:  Xiaoxiao Gu; Kristyn S Masters
Journal:  J Biomed Mater Res A       Date:  2010-06-15       Impact factor: 4.396

9.  Valve interstitial cell tensional homeostasis directs calcification and extracellular matrix remodeling processes via RhoA signaling.

Authors:  Emily J Farrar; Varsha Pramil; Jennifer M Richards; Christopher Z Mosher; Jonathan T Butcher
Journal:  Biomaterials       Date:  2016-07-29       Impact factor: 12.479

Review 10.  Molecular mechanisms underlying the onset of degenerative aortic valve disease.

Authors:  Daihiko Hakuno; Naritaka Kimura; Masatoyo Yoshioka; Keiichi Fukuda
Journal:  J Mol Med (Berl)       Date:  2008-09-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.